IE38775B1 - Benzazepine derivatives - Google Patents

Benzazepine derivatives

Info

Publication number
IE38775B1
IE38775B1 IE123/74A IE12374A IE38775B1 IE 38775 B1 IE38775 B1 IE 38775B1 IE 123/74 A IE123/74 A IE 123/74A IE 12374 A IE12374 A IE 12374A IE 38775 B1 IE38775 B1 IE 38775B1
Authority
IE
Ireland
Prior art keywords
methyl
substituted
chloro
hydrogen
benzyl
Prior art date
Application number
IE123/74A
Other versions
IE38775L (en
Original Assignee
Endo Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US359504A external-priority patent/US3890327A/en
Priority claimed from US05/422,616 external-priority patent/US3932650A/en
Application filed by Endo Lab filed Critical Endo Lab
Publication of IE38775L publication Critical patent/IE38775L/en
Publication of IE38775B1 publication Critical patent/IE38775B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems

Abstract

1449331 Octahydropyridoindolobenzazepines ENDO LABORATORIES Inc 21 Jan 1974 [22 Jan 1973 11 May 1973 6 Dec 1973 (2)] 02657/74 Heading C2C Novel octahydropyridoindolobenzazepines of the general formula n is zero or one; X is an anion of a pharmaceutically suitable acid; and R is hydrogen; 3-chloro-2-butenyl; 2-bromoallyl; benzyl; benzyl ring-substituted with methyl, methoxy or chloro; phenethyl; 3-phenylpropyl; 3-phenylpropyl ring substituted with chloro, bromo or methoxy; furfurtyl; 2-thenyl; acetonyl; phenacyl; C 1 -C 5 , alkyl; C 3 -C 5 alkenyl; C 3 -C 5 alkynyl; cinnamyl; cinnamyl ring-substituted with chloro, bromo, or methoxy; 3-phenyl-2- propynyl; cyclopropyl ; C 4 -C 8 cycloalkylmethyl (methylcyclopropyl)methyl; (cis - 2,3 - dimethylcyclopropyl)methyl; C 6 -C 8 cyclo = alkenylmethyl; C 6 -C 8 cycloalkadienylmethyl; (2,3-dimethylcycloprop- 2 - en - 1 - yl)methyl; exo - 7 - norcarylmethyl; (cis - 1,6 - dimethylendo - 3 - norcaren - 7 - yl)methyl; (4 - methylbicyclo[2.2.2]oct - 1 - yl)methyl; (4 - methylbicyclo[2.2.2]oct - 2 - en - 1 - yl) methyl; (bicyclo[2.2.1]hept - 2 - yl)methyl; bicyclo[2.2.1]- hept - 2 - en - 5 - yl)methyl; 1 - adamantylmethyl; or 2 - adamantylmethyl, and the hydrogens in the 4a and 14a positions are in trans relationship to each other, are prepared (a) when R is R<SP>a</SP>, which is benzyl; benzyl ring- substituted with methyl, methoxy or chloro; phenethyl; 3 - phenylpropyl; 3 - phenylpropyl ring-substituted by chloro, bromo or methoxy; furfuryl; 2-thenyl; C 1 -C 5 alkyl; cyclopropyl; C 4 -C 8 cycloalkylmethyl; (methyl-cyclopropyl)- methyl; exo - 7 - norcarylmethyl; (4 - methylbicyclo[2.2.2]oct - 1 - yl)methyl; (bicyclo- [2.2.1]hept- 2 - yl)methyl; 1 - adamantylmethyl; or 2 - adamantylmethyl, by reducing with a boron hydride/tetrahydrofuran complex a hexahydro pyridoindolobenzazepine of the general formula wherein R<SP>2</SP> is as R<SP>a</SP> or methoxymethyl or -COR<SP>7</SP>, in which R<SP>7</SP> is phenyl; chlorophenyl; methylphenyl; methoxyphenyl; benzylphenethyl; phenethyl ring - substituted by chloro, bromo or methoxy; 2-furyl; 2-thienyl; hydrogen; C 1 -C 4 alkyl; C 2 -C 4 alkenyl; styryl; styryl ring - substituted by chloro, bromo or methoxy; C 2 -C 7 , cycloalkyl; methylcyclopropyl; C 5 -C 7 cycloalkenyl; C 5 -C 7 cycloalkadienyl; exo - 7 - norcaryl; 4 - methylbioyclo- [2.2.2]oct - 1 - yl; bicyclo[2.2.1]hept - 2 - yl; 4 - methyl - bicyclo[2.2.2]oct - 2 - en - 1 - yl; bicyclo[2.2.1]hept - 2 - en - 5 - yl; 1 - adamantyl; or 2 - adamantyl; followed by acidification; (b) when R is hydrogen, by reacting the corresponding compound in which R is R<SP>6</SP>, which is methyl; ethyl; benzyl; benzyl ring- substituted by chloro, methyl or methoxy; or cyclopropylmethyl, with a compound of the general formula ClCOOR<SP>3</SP>, wherein R<SP>3</SP> is C 1 -C 4 alkyl; vinyl; benzyl; p-methylbenzyl; p-methoxybenzyl; or phenyl, and subjecting the resulting ester of the general formula to hydrolysis or, when R<SP>3</SP> is benzyl or substituted benzyl, to hydrolysis or hydrogenolysis; (c) when R is R<SP>c</SP>, which is as R with the exception of hydrogen, cyclopropyl and (cis-2,3-dimethylcyclopropyl)methyl, by alkylating the corresponding compound in which R is hydrogen with a compound of the general formula (i) R<SP>c</SP>Z, wherein Z is Cl, Br, I or -OS(O) 2 R<SP>8</SP>, in which R<SP>8</SP> is CH 3 , phenyl or p-tolyl, or (ii) wherein R<SP>9</SP> is C 1 -C 4 alkyl, in the presence of an acid acceptor; (d) when R is R<SP>d</SP>, which is as R with the exception of hydrogen, acetonyl, phenacyl, cyclopropyl, cinnamyl, substituted cinnamyl, 3-phenyl-2-propynyl and (cis-2,3- dimethylcyclopropyl)methyl, by acylating the corresponding compound wherein R is hydrogen with a compound of the general formula QCOR<SP>4</SP>, wherein R<SP>4</SP> is 2-chloro-1-propenyl; 1- bromovinyl; phenyl; chlorophenyl; methylphenyl; methoxyphenyl; benzyl; phenethyl; phenethyl ring-substituted with chloro, bromo, or methoxy; 2-furyl; 2-thienyl; hydrogen; C 1 -C 4 -alkyl; C 2 -C 4 alkenyl; C 2 -C 4 alkynyl; styryl; styryl ring substituted with chloro, bromo, or methoxy; phenylethynyl; C 3 -C 7 cycloalkyl; methylcyclopropyl; C 5 -C 7 cycloalkenyl; C 5 -C 7 cycloalkadienyl; 2,3-dimethylcycloprop - 2 - en - 1 - yl; exo - 7 - norcaryl; cis - 1,6 - dimethyl - endo - 3 - norcaren - 7 - yl; 4 - methyl - bicyclo[2.2.2]oct - 1 - yl; bicyclo- [2.2.1]hept - 2 - yl; 4 - methylbicyclo[2.2.2]- oct - 2 - en - 1 - yl; bicyclo - [2.2.1]hept - 2 - en- 5 - yl; 1 - adamantyl; or 2 - adamantyl; Q is -Cl, -Br, C 1 -C 4 alkoxy; or R<SP>5</SP> is different from R<SP>4</SP> and is C 1 -C 4 alkyl, provided that when R<SP>4</SP> is hydrogen, R<SP>5</SP> is methyl; and R<SP>6</SP> is C 1 -C 4 alkyl; and reducing the resulting ketone of the general formula with a metal hydride; and (e) when R is (cis- 2,3-dimethylcyclopropyl)methyl, by catalytically hydrogenating the corresponding compound in which R is (2,3-dimethylcycloprop-2-en-1-yl)- methyl; followed optionally by salification of a resulting free base. Hexahydropyridoindolobenzazepines of the second general formula above are prepared (a) when R<SP>2</SP> is methoxymethyl, by reacting the corresponding compound in which R<SP>2</SP> is hydrogen with chloromethyl methyl ether; (b) when R<SP>2</SP> is hydrogen, benzyl or -COR<SP>7</SP>, by condensing 5 - amino - 10,11 - dihydro - 5H - dibenz- [b,f]azepine with 4-piperidone, optionally 1- substituted by benzyl or -COR<SP>7</SP>, in the presence of an acid; (c) when R<SP>2</SP> is -CH 2 R<SP>7</SP>, by reducing the corresponding compound in which R<SP>2</SP> is -COR<SP>7</SP>; and (d) when R<SP>2</SP> is -COR<SP>7</SP>, by acylating the corresponding compound in which R<SP>2</SP> is hydrogen. Pharmaceutical compositions having analgesic and sedative-tranquillizer activity comprise, as active ingredient, at least one pyridoindolobenzazepine of the first general formula above, together with a pharmaceutically suitable vehicle. [GB1449331A]
IE123/74A 1973-01-22 1974-01-22 Benzazepine derivatives IE38775B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32535273A 1973-01-22 1973-01-22
US359504A US3890327A (en) 1973-05-11 1973-05-11 Trans-1,2,3,4,4a,8,9,14a-octahydropyrido(r',3':2,3)indolo(1,7-ab)+8 1)benzazepine
US42261573A 1973-12-06 1973-12-06
US05/422,616 US3932650A (en) 1973-01-22 1973-12-06 Trans-octahydropyridoindolobenzazepines as central nervous system depressants

Publications (2)

Publication Number Publication Date
IE38775L IE38775L (en) 1974-07-22
IE38775B1 true IE38775B1 (en) 1978-05-24

Family

ID=27502310

Family Applications (1)

Application Number Title Priority Date Filing Date
IE123/74A IE38775B1 (en) 1973-01-22 1974-01-22 Benzazepine derivatives

Country Status (18)

Country Link
JP (1) JPS49108100A (en)
AR (1) AR207113A1 (en)
AT (1) AT340429B (en)
BE (1) BE809977A (en)
CA (1) CA993872A (en)
CH (1) CH601298A5 (en)
DD (1) DD111906A5 (en)
DE (1) DE2402391A1 (en)
FR (1) FR2214478B1 (en)
GB (1) GB1449331A (en)
HU (1) HU169309B (en)
IE (1) IE38775B1 (en)
IL (1) IL44042A (en)
LU (1) LU69210A1 (en)
NL (1) NL7400849A (en)
NO (1) NO140822C (en)
PH (1) PH11128A (en)
SE (1) SE407802B (en)

Also Published As

Publication number Publication date
JPS49108100A (en) 1974-10-14
AT340429B (en) 1977-12-12
ATA50074A (en) 1977-04-15
HU169309B (en) 1976-11-28
LU69210A1 (en) 1975-04-11
BE809977A (en) 1974-07-22
NO140822B (en) 1979-08-13
IL44042A0 (en) 1974-05-16
IE38775L (en) 1974-07-22
SE407802B (en) 1979-04-23
DD111906A5 (en) 1975-03-12
NL7400849A (en) 1974-07-24
DE2402391A1 (en) 1974-07-25
GB1449331A (en) 1976-09-15
PH11128A (en) 1977-10-27
CH601298A5 (en) 1978-07-14
IL44042A (en) 1977-02-28
CA993872A (en) 1976-07-27
FR2214478B1 (en) 1978-01-13
AU6470774A (en) 1975-07-24
NO140822C (en) 1979-11-21
FR2214478A1 (en) 1974-08-19
NO740177L (en) 1974-07-23
AR207113A1 (en) 1976-09-15

Similar Documents

Publication Publication Date Title
Matsmura et al. Stereoselective syntheses of solenopsin A and B
GB1450002A (en) Pyridoindoles
Yadav et al. Cyclopentane synthesis and annulation: intramolecular radical cyclization of acetals
EP0996619A1 (en) Tropane analogs and methods for inhibition of monoamine transport
IE38775B1 (en) Benzazepine derivatives
Umezawa et al. A synthesis of (±)-Δ2-α-Lycoren-7-one, the key intermediate for the total synthesis of (±)-lycorine
Sauers et al. Stereochemistry of Reactions of 7-Norbornenyl Anions
KAHN et al. Design and synthesis of nonpeptide mimetics of jaspamide
Macdonald et al. Pyrrolizidine alkaloid synthesis.(.+-.)-Supinidine
Moursounidis et al. A synthesis and some reactions of 7-Oxabicyclo [2.2. 1] heptan-2-one
Hino et al. Synthesis of bioactive nitrogen heterocycles from marine organisms
Cainelli et al. A synthetic approach to 4-oxo and 4-thioxo azetidinones from heterocumulenes and ester enolates. A novel synthesis of 4-thio-acetoxy azetidin-2-ones.
Garin Cyclobutene epoxides. Stereospecific Lewis acid rearrangement
Wolfe et al. Dianions derived from glutarimide, 3, 5-morpholinedione, and 3, 5-thiomorpholinedione as useful new synthetic intermediates
Alber et al. 6-Methyltetracyclo [4.2. 0.01, 7.05, 7] octane-a bridged [3.3. 3] fenestrane
Schaub et al. Prostaglandins and congeners II. The conjugate addition of 3-t-butoxyoctyl magnesium bromide to cyclopentenones. A synthesis of rac. 11-deoxy-13-dihydroprostaglandin-E1.
HAGIWARA Annulation via Sequential Multifold Michael Reaction-One Aspect of Terpenoid Synthesis
GB1289273A (en)
ES364930A1 (en) 10 (or 11) - dihald - 5-(3-dimethylaminopropyl or -propylidene) - 5h-dibenzo(a
IMANISHI et al. 1, 6-Dihydro-3 (2H)-pyridinones. II. Synthesis of 2-Azabicyclo [2. 2. 2] octanes by the Reaction of N-Substituted 1, 6-Dihydro-3 (2H)-pyridinones with 1, 3-Dicarbonyl Compounds
Goldberg et al. Alumina-catalyzed dehydration of 1-ferrocenylethanol. Formation of 1, 3-diferrocenyl-1-butene
Veselovsky et al. Cationic cyclization of regular α-monoterpenols as a model for tri-and tetracyclic diterpene biosynthesis
Walter et al. Annelation of ethyl propiolate with ethyl pipecolate
Jeng et al. Formation of Pyrrole Derivatives from Heteroatom‐Substituted Acetonitriles
Kawano et al. Thermal cyclization of 1-{(Z)-1-hexene-3, 5-diynyl}-2-(1, 3-butanediynyl) benzene leading to dinaphtho [1, 2-b: 2, 1-f] semibullvalene and dinaphtho [2, 1-b: 1, 2-j] elassovalene skeletons via cyclobuta [a] naphthalene